SemGroup Corporation to Participate in UBS MLP Conference
Jan 06, 2017 21:15 pm UTC| Business
TULSA, Okla., Jan. 06, 2017 -- SemGroup® Corporation (NYSE:SEMG) will attend the UBS MLP One-on-One Conference in Park City, Utah on Tuesday, Jan. 10 and Wednesday, Jan. 11. SemGroup Chief Executive Officer Carlin...
Noble Energy Will Host Its Year End 2016 Results Conference Call and Webcast on February 14th
Jan 06, 2017 21:15 pm UTC| Business
Houston, Jan. 06, 2017 -- Noble Energy, Inc. (NYSE: NBL) will host its fourth quarter and year end 2016 results conference call and webcast at 8:00 a.m., Central Time, Tuesday, February 14, 2017. The Company plans to...
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 06, 2017 21:12 pm UTC| Business
LEXINGTON, Mass., Jan. 06, 2017 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...
Schmitt Industries Announces Second Quarter Fiscal 2017 Operating Results
Jan 06, 2017 21:10 pm UTC| Business
PORTLAND, Ore., Jan. 06, 2017 -- Schmitt Industries, Inc. (NASDAQ:SMIT) today announced its operating results for the three and six months ended November 30, 2016. For the three months ended November 30, 2016, total...
Kirk Lloyd promoted to Chief Lending Officer – Commercial Real Estate
Jan 06, 2017 21:05 pm UTC| Business
BROOKLYN, N.Y., Jan. 06, 2017 -- Kenneth J. Mahon, Chief Executive Officer and President of Dime Community Bancshares, Inc.(the “Company” or “Dime”) (NASDAQ:DCOM), the parent company of Dime Community Bank (the “bank”),...
Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer
Jan 06, 2017 21:01 pm UTC| Business
MORRISTOWN, N.J., Jan. 06, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on pain and CNS conditions, today announced the appointment of KenPiñaas Senior Vice...
Jan 06, 2017 21:01 pm UTC| Business
BASKING RIDGE, N.J., Jan. 06, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining a select therapeutic development pipeline with an industry-leading...